1887
  1. Home
  2. A-Z Publications
  3. Qatar Medical Journal
  4. Volume 2020, Issue 1
  5. Article
Volume 2020, Issue 1
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Computed tomography (CT) features of cystic fibrosis (CF) lung disease can be objectively quantified using current CT scoring systems to assess the extent and severity of the disease. The aims of this study were to calculate the Santamaria CT scores in adult patients with CF with the predominant CFTR I1234V genotype, determine its reliability, and correlate these parameters with lung function, microbial colonization, compliance to treatment, and exacerbations. This retrospective observational study was conducted on adult patients with CF who were regularly followed up in the adult CF service at Qatar via CT scans that were taken not during an acute exacerbation. CT scans were scored using the Santamaria scoring system. Corresponding spirometry, microbiological data of sputum culture, and relevant clinical data were correlated with individual CT scores. Only 23 of the 31 patients underwent CT when not in an acute exacerbation and were included in the study analysis. A total of 20 (87%) patients had the I1234V genotype. There was good agreement between the two radiologists on the Santamaria CT scores with an intraclass correlation coefficient (ICC) value of 0.991. Bronchiectasis was the most consistent finding, followed by interlobular and intralobular septal thickening. Patients with poor lung function and frequent exacerbations had significantly higher CT scores ( = 0.015). The CT scores of patients colonized with were higher but nonsignificant ( = 0.20). The mean CT scores were significantly higher in patients who were noncompliant to regular treatment than in those who were compliant ( = 0.012). Santamaria CT scores comprise a reliable scoring system for adult patients with CF and can be used to determine the extent and severity of lung disease. colonization causes more structural lung damage than other common colonizing organisms. Noncompliance to treatment has a significant impact on the increasing severity of CF lung disease.

© 2020 Thomas, Raja, Albakri, Najim, Chandra, Allangawi, licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/qmj.2020.4
2020-04-09
2024-04-27
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2020/1/qmj.2020.4.html?itemId=/content/journals/10.5339/qmj.2020.4&mimeType=html&fmt=ahah

References

  1. Flume PA, O'Sullivan BO, Robinson KA, Goss CH, Mogayzel PJ Jr, Willey- Courand DB, Finder J, Lester M, Quittell L, Rosenblatt R. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2007; 176:10:957–969.
     [Google Scholar]
  2. Burns JL, Emerson J, Stapp JR, Yim DL, Krzewinski J, Louden L, Ramsey BW, Clausen CR. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis. 1998; 27:1:158–163.
     [Google Scholar]
  3. Rosenfeld M, Ramsey BW, Gibson RL. Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management. Curr Opin Pulm Med. 2003; 9:6:492–497.
     [Google Scholar]
  4. Danders DB, Li Z, Brody AS. Chest computed tomography predicts the frequency of pulmonary exacerbations in children with cystic fibrosis. Annals ATS. 2015; 12:1:64–69.
     [Google Scholar]
  5. Bhalla M, Turcios N, Aponte V, Jenkins M, Leitman BS, McCauley DI, Naidich DP. Cystic fibrosis: scoring system with thin-section CT. Radiology. 1991; 179:3:783–788.
     [Google Scholar]
  6. Brody AS, Molina PL, Klein JS, Rothman BS, Ramagopal M, Swartz DR. High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate. Pediatr Radiol. 1999; 29:10:731–735.
     [Google Scholar]
  7. Santamaria F, Grillo G, Guidi G, Rotondo A, Raia V, de Ritis G, Sarnelli P, Caterino M, Greco L. Cystic fibrosis: when should high-resolution computed tomography of the chest be obtained? Pediatrics. 1998; 101:5:908–913.
     [Google Scholar]
  8. de Jong PA, Ottink MD, Robben SGF, Lequin MH, Hop WCJ, Hendriks JJE, Pare PD, Tiddens HAWM. Pulmonary disease assessment in cystic fibrosis: Comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology. 2004; 231::434–439.
     [Google Scholar]
  9. Bhat V, Wahab AA, Garg KC, Janahi I, Singh R. HRCT in cystic fibrosis in patients with CFTR I1234V mutation: Assessment of scoring systems with low dose technique using multidetector system and correlation with pulmonary function tests. Indian J Radiol Imaging. 2015; 25:1:44–51.
     [Google Scholar]
  10. Abdul Wahab A, Dawod ST, al Thani G. Cystic fibrosis in a large kindred family in Qatar. Ann Trop Paediatr. 2000; 20:3:203–207.
     [Google Scholar]
  11. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995; 152:3:1107–1136.
     [Google Scholar]
  12. UK Cystic Fibrosis Registry Annual Data Report 2012.
  13. de Jong PA, Lindblad A, Rubin L, Hop WC, de Jongste JC, Brink M, Tiddens HA. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax. 2006; 61:1:80–85.
     [Google Scholar]
  14. Loeve M, Krestin GP, Rosenfeld M, de-Bruijne M, Stick SM, Tiddens HA. Chest computed tomography: a validated surrogate endpoint of cystic fibrosis lung disease? Eur Respir J. 2013; 42:3:844–857.
     [Google Scholar]
  15. Helbich TH, Heinz-Peer G, Eichler I, Wunderbaldinger P, Gotz M, Wojnarowski C, Brasch RC, Herold CJ. Cystic fibrosis: CT assessment of lung involvement in children and adults. Radiology. 1999; 213:2:537–544.
     [Google Scholar]
  16. Brody AS. Early morphologic changes in the lungs of asymptomatic infants and young children with cystic fibrosis. J Pediatr. 2004; 144:2:154–161.
     [Google Scholar]
  17. Brody AS, Klein JS, Molina PL, Quan J, Bean JA, Wilmott RW. High-resolution computed tomography in young patients with cystic fibrosis: Distribution of abnormalities and correlation with pulmonary function tests. J Pediatr. 2004; 145:1:32–38.
     [Google Scholar]
  18. de-Jong PA, Nakano Y, Lequin MH, Mayo JR, Woods R, Paré PD, Tiddens HA. Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J. 2004; 23:1:93–97.
     [Google Scholar]
  19. Sanders DB, Bittner RC, Rosenfeld M, Redding GJ, Goss CH. Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Pediatr Pulmonol. 2011; 46::393–400.
     [Google Scholar]
  20. Farrell PM, Collins J, Broderick LS, Rock MJ, Li Z, Kosorok MR, Laxova A, Gershan WM, Brody AS. Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis. Radiology. 2009; 252:2:534–543.
     [Google Scholar]
  21. Folescu TW, Marques ED, Boechat MC, Daltro P, Higa LY, Cohen RW. High-resolution computed tomography scores in cystic fibrosis patients colonized with Pseudomonas aeruginosa or Staphylococcus aureus. J Bras Pneumol. 2012; 38:1:41–49.
     [Google Scholar]
  22. Wiesemann HG, Steinkamp G, Ratjen F, Bauernfeind A, Przyklenk B, Döring G, von-der-Hardt H. Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis. Pediatr Pulmonol. 1998; 25:2:88–92.
     [Google Scholar]
  23. Edmondson C, Davies JC. Current and future treatment options for cystic fibrosis lung disease: latest evidence and clinical implications. Ther Adv Chronic Dis. 2016; 7:3:170–183.
     [Google Scholar]
  24. Eakin MN, Riekert KA. The impact of medication adherence on lung health outcomes in cystic fibrosis. Curr Opin Pulm Med. 2013; 19:6:687–691.
     [Google Scholar]
  25. Arias LRP, Bousoño GC, Díaz MJJ. Treatment compliance in children and adults with cystic fibrosis. J Cyst Fibrosis. 2008; 7:5:359–367.
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2020.4
Loading
CT score and correlation with lung function and microbiology of adult patients with cystic fibrosis with predominant I1234V genotype in Qatar
Qatar Medical Journal 2020, 4 (2020); https://doi.org/10.5339/qmj.2020.4
/content/journals/10.5339/qmj.2020.4
/content/journals/10.5339/qmj.2020.4
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): CT score, Cystic fibrosis, lung function and microbiology

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error